High levels of homocysteine downregulate apolipoprotein E expression via nuclear factor kappa B.

Autor:	Trusca VG; Violeta G Trusca, Elena V Fuior, Ioana M Fenyo, Anca V Gafencu, Department of Genomics, Transcriptomics and Molecular Therapies, Institute of Cellular Biology and Pathology, 'Nicolae Simionescu' of the Romanian Academy, 050568 Bucharest, Romania., Mihai AD; Violeta G Trusca, Elena V Fuior, Ioana M Fenyo, Anca V Gafencu, Department of Genomics, Transcriptomics and Molecular Therapies, Institute of Cellular Biology and Pathology, 'Nicolae Simionescu' of the Romanian Academy, 050568 Bucharest, Romania., Fuior EV; Violeta G Trusca, Elena V Fuior, Ioana M Fenyo, Anca V Gafencu, Department of Genomics, Transcriptomics and Molecular Therapies, Institute of Cellular Biology and Pathology, 'Nicolae Simionescu' of the Romanian Academy, 050568 Bucharest, Romania., Fenyo IM; Violeta G Trusca, Elena V Fuior, Ioana M Fenyo, Anca V Gafencu, Department of Genomics, Transcriptomics and Molecular Therapies, Institute of Cellular Biology and Pathology, 'Nicolae Simionescu' of the Romanian Academy, 050568 Bucharest, Romania., Gafencu AV; Violeta G Trusca, Elena V Fuior, Ioana M Fenyo, Anca V Gafencu, Department of Genomics, Transcriptomics and Molecular Therapies, Institute of Cellular Biology and Pathology, 'Nicolae Simionescu' of the Romanian Academy, 050568 Bucharest, Romania.
Jazyk:	angličtina
Zdroj:	World journal of biological chemistry [World J Biol Chem] 2016 Feb 26; Vol. 7 (1), pp. 178-87.
DOI:	10.4331/wjbc.v7.i1.178
Abstrakt:	Aim: To investigate the effect of high homocysteine (Hcy) levels on apolipoprotein E (apoE) expression and the signaling pathways involved in this gene regulation. Methods: Reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot were used to assess apoE expression in cells treated with various concentrations (50-500 μmol/L) of Hcy. Calcium phosphate-transient transfections were performed in HEK-293 and RAW 264.7 cells to evaluate the effect of Hcy on apoE regulatory elements [promoter and distal multienhancer 2 (ME2)]. To this aim, plasmids containing the proximal apoE promoter [(-500/+73)apoE construct] alone or in the presence of ME2 [ME2/(-500/+73)apoE construct] to drive the expression of the reporter luciferase gene were used. Co-transfection experiments were carried out to investigate the downstream effectors of Hcy-mediated regulation of apoE promoter by using specific inhibitors or a dominant negative form of IKβ. In other co-transfections, the luciferase reporter was under the control of synthetic promoters containing multiple specific binding sites for nuclear factor kappa B (NF-κB), activator protein-1 (AP-1) or nuclear factor of activated T cells (NFAT). Chromatin immunoprecipitation (ChIP) assay was accomplished to detect the binding of NF-κB p65 subunit to the apoE promoter in HEK-293 treated with 500 μmol/L Hcy. As control, cells were incubated with similar concentration of cysteine. NF-κB p65 proteins bound to DNA were immunoprecipitated with anti-p65 antibodies and DNA was identified by PCR using primers amplifying the region -100/+4 of the apoE gene. Results: RT-PCR revealed that high levels of Hcy (250-750 μmol/L) induced a 2-3 fold decrease in apoE mRNA levels in HEK-293 cells, while apoE gene expression was not significantly affected by treatment with lower concentrations of Hcy (100 μmol/L). Immunoblotting data provided additional evidence for the negative role of Hcy in apoE expression. Hcy decreased apoE promoter activity, in the presence or absence of ME2, in a dose dependent manner, in both RAW 264.7 and HEK-293 cells, as revealed by transient transfection experiments. The downstream effectors of the signaling pathways of Hcy were also investigated. The inhibitory effect of Hcy on the apoE promoter activity was counteracted by MAPK/ERK kinase 1/2 (MEK1/2) inhibitor U0126, suggesting that MEK1/2 is involved in the downregulation of apoE promoter activity by Hcy. Our data demonstrated that Hcy-induced inhibition of apoE took place through activation of NF-κB. Moreover, we demonstrated that Hcy activated a synthetic promoter containing three NF-κB binding sites, but did not affect promoters containing AP-1 or NFAT binding sites. ChIP experiments revealed that NF-κB p65 subunit is recruited to the apoE promoter following Hcy treatment of cells. Conclusion: Hcy-induced stress negatively modulates apoE expression via MEK1/2 and NF-κB activation. The decreased apoE expression in peripheral tissues may aggravate atherosclerosis, neurodegenerative diseases and renal dysfunctions.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu